US Stock MarketDetailed Quotes

ENLV Enlivex Therapeutics

Watchlist

1.140
+0.070+6.54%

Close Nov 27 16:00 ET

1.120
-0.020-1.75%

Post 20:01 ET

24.40MMarket Cap-966P/E (TTM)

Enlivex Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-55.09%2.99M

-41.77%3.95M

-2.50%25.15M

-22.36%6.09M

-0.86%5.63M

13.25%6.65M

5.92%6.78M

33.75%25.8M

0.40%7.85M

46.92%5.68M

Selling and administrative expenses

-38.85%987K

-31.99%1.09M

-21.92%5.23M

-57.95%733K

-13.35%1.28M

-8.35%1.61M

-6.68%1.61M

7.40%6.7M

-29.75%1.74M

24.56%1.48M

-General and administrative expense

-38.85%987K

-31.99%1.09M

-21.92%5.23M

-57.95%733K

-13.35%1.28M

-8.35%1.61M

-6.68%1.61M

7.40%6.7M

-29.75%1.74M

24.56%1.48M

Research and development costs

-60.30%2M

-44.80%2.86M

1.71%19.01M

-21.89%4.45M

3.52%4.35M

22.51%5.04M

10.55%5.18M

45.12%18.69M

10.34%5.7M

56.81%4.2M

Other operating expenses

----

125.37%906K

----

140.72%402K

----

Operating profit

55.09%-2.99M

41.77%-3.95M

2.50%-25.15M

22.36%-6.09M

0.86%-5.63M

-13.25%-6.65M

-5.92%-6.78M

-33.75%-25.8M

-0.40%-7.85M

-46.92%-5.68M

Net non-operating interest income expense

23.08%-110K

102.53%11K

88.92%1.55M

-143K

-435K

494.71%821K

Non-operating interest income

----

87.43%1.57M

----

595.83%835K

----

Total other finance cost

-23.08%110K

-102.53%-11K

0.00%14K

----

--143K

--435K

-95.73%14K

----

Other net income (expense)

-201K

10.12%-5.47M

-2,660.61%-4.56M

-498.21%-335K

-221.00%-6.08M

-105.02%-165K

-112.73%-56K

Gain on sale of security

----

79.88%-1.22M

----

-221.00%-6.08M

----

Special income (charges)

--0

---201K

---4.24M

----

--0

----

-Gain on sale of property,plant,equipment

--0

---201K

---4.24M

----

--0

----

Other non- operating income (expenses)

----

-498.21%-335K

----

-112.73%-56K

Income before tax

54.42%-3.1M

42.64%-4.14M

6.41%-29.07M

-26.51%-9.1M

-4.01%-5.96M

31.48%-6.79M

12.24%-7.22M

-114.68%-31.06M

-51.79%-7.19M

-67.44%-5.73M

Income tax

Net income

54.42%-3.1M

42.64%-4.14M

6.41%-29.07M

-26.51%-9.1M

-4.01%-5.96M

31.48%-6.79M

12.24%-7.22M

-114.68%-31.06M

-51.79%-7.19M

-67.44%-5.73M

Net income continuous Operations

54.42%-3.1M

42.64%-4.14M

6.41%-29.07M

-26.51%-9.1M

-4.01%-5.96M

31.48%-6.79M

12.24%-7.22M

-114.68%-31.06M

-51.79%-7.19M

-67.44%-5.73M

Minority interest income

Net income attributable to the parent company

54.42%-3.1M

42.64%-4.14M

6.41%-29.07M

-26.51%-9.1M

-4.01%-5.96M

31.48%-6.79M

12.24%-7.22M

-114.68%-31.06M

-51.79%-7.19M

-67.44%-5.73M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

54.42%-3.1M

42.64%-4.14M

6.41%-29.07M

-26.51%-9.1M

-4.01%-5.96M

31.48%-6.79M

12.24%-7.22M

-114.68%-31.06M

-51.79%-7.19M

-67.44%-5.73M

Basic earnings per share

56.76%-0.16

43.59%-0.22

7.69%-1.56

-23.08%-0.48

-3.23%-0.32

31.48%-0.37

13.33%-0.39

-108.64%-1.69

-44.44%-0.39

-63.16%-0.31

Diluted earnings per share

56.76%-0.16

43.59%-0.22

7.69%-1.56

-23.08%-0.48

-3.23%-0.32

31.48%-0.37

13.33%-0.39

-108.64%-1.69

-44.44%-0.39

-63.16%-0.31

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-55.09%2.99M	-41.77%3.95M	-2.50%25.15M	-22.36%6.09M	-0.86%5.63M	13.25%6.65M	5.92%6.78M	33.75%25.8M	0.40%7.85M	46.92%5.68M
Selling and administrative expenses	-38.85%987K	-31.99%1.09M	-21.92%5.23M	-57.95%733K	-13.35%1.28M	-8.35%1.61M	-6.68%1.61M	7.40%6.7M	-29.75%1.74M	24.56%1.48M
-General and administrative expense	-38.85%987K	-31.99%1.09M	-21.92%5.23M	-57.95%733K	-13.35%1.28M	-8.35%1.61M	-6.68%1.61M	7.40%6.7M	-29.75%1.74M	24.56%1.48M
Research and development costs	-60.30%2M	-44.80%2.86M	1.71%19.01M	-21.89%4.45M	3.52%4.35M	22.51%5.04M	10.55%5.18M	45.12%18.69M	10.34%5.7M	56.81%4.2M
Other operating expenses	----	----	125.37%906K	----	----	----	----	140.72%402K	----	----
Operating profit	55.09%-2.99M	41.77%-3.95M	2.50%-25.15M	22.36%-6.09M	0.86%-5.63M	-13.25%-6.65M	-5.92%-6.78M	-33.75%-25.8M	-0.40%-7.85M	-46.92%-5.68M
Net non-operating interest income expense	23.08%-110K	102.53%11K	88.92%1.55M			-143K	-435K	494.71%821K
Non-operating interest income	----	----	87.43%1.57M	----	----	----	----	595.83%835K	----	----
Total other finance cost	-23.08%110K	-102.53%-11K	0.00%14K	----	----	--143K	--435K	-95.73%14K	----	----
Other net income (expense)		-201K	10.12%-5.47M	-2,660.61%-4.56M	-498.21%-335K			-221.00%-6.08M	-105.02%-165K	-112.73%-56K
Gain on sale of security	----	----	79.88%-1.22M	----	----	----	----	-221.00%-6.08M	----	----
Special income (charges)	--0	---201K	---4.24M	----	----	--0	--0	--0	----	----
-Gain on sale of property,plant,equipment	--0	---201K	---4.24M	----	----	--0	--0	--0	----	----
Other non- operating income (expenses)	----	----	----	----	-498.21%-335K	----	----	----	----	-112.73%-56K
Income before tax	54.42%-3.1M	42.64%-4.14M	6.41%-29.07M	-26.51%-9.1M	-4.01%-5.96M	31.48%-6.79M	12.24%-7.22M	-114.68%-31.06M	-51.79%-7.19M	-67.44%-5.73M
Income tax
Net income	54.42%-3.1M	42.64%-4.14M	6.41%-29.07M	-26.51%-9.1M	-4.01%-5.96M	31.48%-6.79M	12.24%-7.22M	-114.68%-31.06M	-51.79%-7.19M	-67.44%-5.73M
Net income continuous Operations	54.42%-3.1M	42.64%-4.14M	6.41%-29.07M	-26.51%-9.1M	-4.01%-5.96M	31.48%-6.79M	12.24%-7.22M	-114.68%-31.06M	-51.79%-7.19M	-67.44%-5.73M
Minority interest income
Net income attributable to the parent company	54.42%-3.1M	42.64%-4.14M	6.41%-29.07M	-26.51%-9.1M	-4.01%-5.96M	31.48%-6.79M	12.24%-7.22M	-114.68%-31.06M	-51.79%-7.19M	-67.44%-5.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	54.42%-3.1M	42.64%-4.14M	6.41%-29.07M	-26.51%-9.1M	-4.01%-5.96M	31.48%-6.79M	12.24%-7.22M	-114.68%-31.06M	-51.79%-7.19M	-67.44%-5.73M
Basic earnings per share	56.76%-0.16	43.59%-0.22	7.69%-1.56	-23.08%-0.48	-3.23%-0.32	31.48%-0.37	13.33%-0.39	-108.64%-1.69	-44.44%-0.39	-63.16%-0.31
Diluted earnings per share	56.76%-0.16	43.59%-0.22	7.69%-1.56	-23.08%-0.48	-3.23%-0.32	31.48%-0.37	13.33%-0.39	-108.64%-1.69	-44.44%-0.39	-63.16%-0.31
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data